October 9, 2024

PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting – Business Wire

October 2, 2024

Insilico Medicine reports positive results for idiopathic pulmonary fibrosis therapy – PharmaTimes

September 27, 2024

Identification of immune patterns in idiopathic pulmonary fibrosis patients driven by PLA2G7-positive macrophages using an integrated machine learning survival framework – Nature.com

September 27, 2024

Lung-Targeting Perylenediimide Nanocomposites for Efficient Therapy of Idiopathic Pulmonary Fibrosis – ACS Publications

September 20, 2024

Bioinformatics analysis based on extracted ingredients combined with network pharmacology, molecular docking and molecular dynamics simulation to explore the mechanism of Jinbei oral liquid in the therapy of Idiopathic Pulmonary Fibrosis – ScienceDirect.com